Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gisbert

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2013
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant womenN Pedersen, A Bortoli, D Duricova, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2015
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatmentsJ P Gisbert, M Romano, A G Gravina, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.
The American Journal of Gastroenterology|May 2, 2018
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA RegistryI Ordás, E Domènech, M Mañosa, et al.
The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.
The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2013
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant womenN Pedersen, A Bortoli, D Duricova, et al.
Gut|June 26, 2010
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyC Loras, J P Gisbert, M Mínguez, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2015
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatmentsJ P Gisbert, M Romano, A G Gravina, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.
The American Journal of Gastroenterology|May 2, 2018
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA RegistryI Ordás, E Domènech, M Mañosa, et al.
The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.
The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.
Pageof 22